AI Article Synopsis

  • Peptide microarrays are a powerful tool for analyzing kinase activity across various species without needing specific reagents.
  • PIIKA software was developed to enhance the analysis and visualization of data from these arrays, with the latest version, PIIKA 2.5, introducing new quality control metrics and background correction techniques.
  • These improvements help identify and resolve technical issues, ensuring more accurate and consistent kinome analysis that enhances the reliability of results.

Article Abstract

Peptide microarrays consisting of defined phosphorylation target sites are an effective approach for high throughput analysis of cellular kinase (kinome) activity. Kinome peptide arrays are highly customizable and do not require species-specific reagents to measure kinase activity, making them amenable for kinome analysis in any species. Our group developed software, Platform for Integrated, Intelligent Kinome Analysis (PIIKA), to enable more effective extraction of meaningful biological information from kinome peptide array data. A subsequent version, PIIKA2, unveiled new statistical tools and data visualization options. Here we introduce PIIKA 2.5 to provide two essential quality control metrics and a new background correction technique to increase the accuracy and consistency of kinome results. The first metric alerts users to improper spot size and informs them of the need to perform manual resizing to enhance the quality of the raw intensity data. The second metric uses inter-array comparisons to identify outlier arrays that sometimes emerge as a consequence of technical issues. In addition, a new background correction method, background scaling, can sharply reduce spatial biases within a single array in comparison to background subtraction alone. Collectively, the modifications of PIIKA 2.5 enable identification and correction of technical issues inherent to the technology and better facilitate the extraction of meaningful biological information. We show that these metrics demonstrably enhance kinome analysis by identifying low quality data and reducing batch effects, and ultimately improve clustering of treatment groups and enhance reproducibility. The web-based and stand-alone versions of PIIKA 2.5 are freely accessible at via http://saphire.usask.ca.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432839PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0257232PLOS

Publication Analysis

Top Keywords

kinome analysis
16
quality control
8
peptide microarrays
8
kinome
8
kinome peptide
8
piika enable
8
extraction meaningful
8
meaningful biological
8
background correction
8
technical issues
8

Similar Publications

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). These malignancies develop within preexisting benign lesions called plexiform neurofibromas (PNs). PNs are solely driven by biallelic loss eliciting RAS pathway activation, and they respond favorably to MEK inhibitor therapy.

View Article and Find Full Text PDF

Introduction: Treatment with Sunitinib, a potent multitargeted receptor tyrosine kinase inhibitor (TKI) has increased the progression-free survival (PFS) and overall-survival (OS) of patients with metastasized renal cell carcinoma (mRCC). With modest OS improvement and variable response and toxicity predictive and/or prognostic biomarkers are needed to personalize patient management: Prediction of individual TKI therapy response and resistance will increase successful treatment outcome while reducing unnecessary drug use and expense. The aim of this study was to investigate whether kinase activity analysis can predict sunitinib response and/or toxicity using tissue samples obtained from primary clear cell RCC (ccRCC) from a cohort of clinically annotated patients with mRCC receiving sunitinib as first-line treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Protein kinases are crucial for plant growth and responses to stress, but research on these proteins in sunflowers is limited compared to other crops like soybean and cotton.
  • A comprehensive study identified 2,583 protein kinases in sunflowers, classifying them into 22 families and 121 subfamilies, with three specific subfamilies showing significant growth.
  • The research also analyzed how these kinases respond to different stresses, ultimately identifying 73 key protein kinases involved in essential signaling pathways, contributing valuable foundational data to the field.
View Article and Find Full Text PDF

HSPB4 and HSPB5 (α-crystallins) have shown increasing promise as neuroprotective agents, demonstrating several anti-apoptotic and protective roles in disorders such as multiple sclerosis and diabetic retinopathy. HSPs are highly regulated by post-translational modification, including deamidation, glycosylation, and phosphorylation. Among them, T148 phosphorylation has been shown to regulate the structural and functional characteristics of HSPB4 and underlie, in part, its neuroprotective capacity.

View Article and Find Full Text PDF

The human kinome has tremendous medical potential. In the past decade, mixed-lineage protein kinase 3 (MLK3) has emerged as an interesting and druggable target in oncogenic signaling. The important role of MLK3 has been demonstrated in several types of cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!